Sfoglia per Autore
Anaplastic large-cell lymphoma
2011-01-01 Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME.
Mechanisms that promote and suppress chromosomal translocations in lymphocytes.
2011-01-01 Gostissa M; Alt FW; Chiarle R.
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer.
2011-01-01 Paola Cappello; Simona Rolla; Roberta Curto; Helen Carnevale; Roberto Chiarle; Federica Cavallo; Mirella Giovarelli; Francesco Novelli
Efficacy of DNA vaccination against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lunger carcinoma (NSCLC)
2011-01-01 C. Voena; C. Mastini; M. Menotti; F. Di Giacomo; D.L. Longo; C. Martinengo; S. Aime; G. Inghirami; R. Chiarle
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma.
2011-01-01 Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P.
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
2011-01-01 Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G.
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells
2011-01-01 Chiarle R; Zhang Y; Frock RL; Lewis SM; Molinie B; Ho YJ; Myers DR; Choi VW; Compagno M; Malkin DJ; Neuberg D; Monti S; Giallourakis CC; Gostissa M; Alt FW.
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
2010-01-01 Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R.
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
2010-01-01 Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P.
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET).
2010-01-01 Marino M; Lattanzio R; Lauriola L; Martucci R; Sioletic S; Gallo E; Palmieri G; Evoli A; Granone P; Palestro G; Chiarle R; Barreca A; Pich A; Remotti D; Pisa R; Martelli M; Truini M; Ascani S; Ruco L; Rendina EA; Tunesi G; Antimi M; Lalle M; Carlini S; Facciolo F; Piantelli M.
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling.
2010-01-01 Gonzalo P; Guadamillas MC; Hernández-Riquer MV; Pollán A; Grande-García A; Bartolomé RA; Vasanji A; Ambrogio C; Chiarle R; Teixidó J; Risteli J; Apte SS; del Pozo MA; Arroyo AG.
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes
2010-01-01 Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F.
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene
2010-01-01 Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V.
The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.
2010-01-01 Zhang Y; Gostissa M; Hildebrand DG; Becker MS; Boboila C; Chiarle R; Lewis S; Alt FW.
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
2009-01-01 Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
2009-01-01 Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R.
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing
2009-01-01 Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
Constitutively active Stat3 triggers the development of autoimmune myocarditis
2009-01-01 Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V
Constitutively active STAT3 triggers the development of autoimmune myocarditis
2009-01-01 Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V
Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin
2009-01-01 Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anaplastic large-cell lymphoma | 2011 | Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME. | |
| Mechanisms that promote and suppress chromosomal translocations in lymphocytes. | 2011 | Gostissa M; Alt FW; Chiarle R. | |
| DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. | 2011 | Paola Cappello; Simona Rolla; Roberta Curto; Helen Carnevale; Roberto Chiarle; Federica Cavallo; Mirella Giovarelli; Francesco Novelli | |
| Efficacy of DNA vaccination against Anaplastic Lymphoma Kinase (ALK) in Non Small Cell Lunger carcinoma (NSCLC) | 2011 | C. Voena; C. Mastini; M. Menotti; F. Di Giacomo; D.L. Longo; C. Martinengo; S. Aime; G. Inghirami; R. Chiarle | |
| Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma. | 2011 | Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P. | |
| Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. | 2011 | Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G. | |
| Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells | 2011 | Chiarle R; Zhang Y; Frock RL; Lewis SM; Molinie B; Ho YJ; Myers DR; Choi VW; Compagno M; Malkin DJ; Neuberg D; Monti S; Giallourakis CC; Gostissa M; Alt FW. | |
| Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. | 2010 | Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R. | |
| PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. | 2010 | Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P. | |
| Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). | 2010 | Marino M; Lattanzio R; Lauriola L; Martucci R; Sioletic S; Gallo E; Palmieri G; Evoli A; Granone P; Palestro G; Chiarle R; Barreca A; Pich A; Remotti D; Pisa R; Martelli M; Truini M; Ascani S; Ruco L; Rendina EA; Tunesi G; Antimi M; Lalle M; Carlini S; Facciolo F; Piantelli M. | |
| MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. | 2010 | Gonzalo P; Guadamillas MC; Hernández-Riquer MV; Pollán A; Grande-García A; Bartolomé RA; Vasanji A; Ambrogio C; Chiarle R; Teixidó J; Risteli J; Apte SS; del Pozo MA; Arroyo AG. | |
| Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes | 2010 | Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F. | |
| Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene | 2010 | Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V. | |
| The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. | 2010 | Zhang Y; Gostissa M; Hildebrand DG; Becker MS; Boboila C; Chiarle R; Lewis S; Alt FW. | |
| The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL | 2009 | Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G | |
| NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells | 2009 | Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R. | |
| IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing | 2009 | Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F | |
| Constitutively active Stat3 triggers the development of autoimmune myocarditis | 2009 | Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V | |
| Constitutively active STAT3 triggers the development of autoimmune myocarditis | 2009 | Camporeale A; Marino F; Brero A; Chiarle R; Jensen O; Levi R; Poli V | |
| Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin | 2009 | Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile